Osimertinib | High-Quality Pharmaceutical Reference Standard
Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in the treatment of EGFR-mutated non-small cell lung cancer (NSCLC). It selectively inhibits both EGFR-sensitizing and T790M resistance mutations, reducing tumor growth. Osimertinib API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations.
Osimertinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 7
